RSS
Monofer (iron isomaltoside)
Clinical trial explores effects of intravenous iron on chronic heart failure
Pharmacosmos’ initiates first hard endpoint randomised controlled trial looking at the effect of intravenous (IV) iron in chronic heart failure (CHF) Read more